Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Treatment trends and outcomes of small-cell carcinoma of the bladder.

Koay EJ, Teh BS, Paulino AC, Butler EB.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):64-70. doi: 10.1016/j.ijrobp.2011.05.039. Epub 2011 Oct 20.

PMID:
22019246
[PubMed - indexed for MEDLINE]
2.

Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.

Choong NW, Quevedo JF, Kaur JS.

Cancer. 2005 Mar 15;103(6):1172-8.

PMID:
15700264
[PubMed - indexed for MEDLINE]
Free Article
3.

Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns.

Patel SG, Stimson CJ, Zaid HB, Resnick MJ, Cookson MS, Barocas DA, Chang SS.

J Urol. 2014 Feb;191(2):329-34. doi: 10.1016/j.juro.2013.09.009. Epub 2013 Sep 12.

PMID:
24036236
[PubMed - indexed for MEDLINE]
4.

A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.

Koay EJ, Teh BS, Paulino AC, Butler EB.

Cancer. 2011 Dec 1;117(23):5325-33. doi: 10.1002/cncr.26197. Epub 2011 May 12.

PMID:
21567387
[PubMed - indexed for MEDLINE]
Free Article
5.

Challenges in the treatment of bladder cancer.

Kaufman DS.

Ann Oncol. 2006 May;17 Suppl 5:v106-12. Review.

PMID:
16807436
[PubMed - indexed for MEDLINE]
Free Article
6.

Current status of radiation therapy and combined-modality treatment for bladder cancer.

Rödel C.

Strahlenther Onkol. 2004 Nov;180(11):701-9. Review.

PMID:
15549188
[PubMed - indexed for MEDLINE]
7.

Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database.

Schreiber D, Rineer J, Weiss J, Leaf A, Karanikolas N, Rotman M, Schwartz D.

Am J Clin Oncol. 2013 Apr;36(2):126-31. doi: 10.1097/COC.0b013e3182438c71.

PMID:
22391430
[PubMed - indexed for MEDLINE]
8.

The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?

Wo JY, Shipley WU, Dahl DM, Coen JJ, Heney NM, Kaufman DS, Zietman AL.

BJU Int. 2009 Jul;104(2):179-83. doi: 10.1111/j.1464-410X.2008.08299.x. Epub 2008 Dec 23.

PMID:
19154448
[PubMed - indexed for MEDLINE]
9.

A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.

Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PM, Harrison SC.

Eur Urol. 2003 Mar;43(3):246-57.

PMID:
12600427
[PubMed - indexed for MEDLINE]
10.

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

Shipley WU, Kaufman DS, Zehr E, Heney NM, Lane SC, Thakral HK, Althausen AF, Zietman AL.

Urology. 2002 Jul;60(1):62-7; discussion 67-8.

PMID:
12100923
[PubMed - indexed for MEDLINE]
11.

The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.

Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.

BJU Int. 2009 Feb;103(4):475-9. doi: 10.1111/j.1464-410X.2008.08011.x. Epub 2008 Oct 6.

PMID:
18990174
[PubMed - indexed for MEDLINE]
12.

Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.

Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.

Cancer. 2004 Dec 1;101(11):2540-8.

PMID:
15481058
[PubMed - indexed for MEDLINE]
Free Article
13.

Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.

Maarouf AM, Khalil S, Salem EA, ElAdl M, Nawar N, Zaiton F.

BJU Int. 2011 May;107(10):1605-10. doi: 10.1111/j.1464-410X.2010.09564.x. Epub 2010 Sep 3.

PMID:
20825396
[PubMed - indexed for MEDLINE]
14.
15.

Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.

Weiss C, Wittlinger M, Engehausen DG, Krause FS, Ott OJ, Dunst J, Sauer R, Rödel C.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1502-6. Epub 2007 Nov 1.

PMID:
17935905
[PubMed - indexed for MEDLINE]
16.

Bladder preservation by combined modality therapy for invasive bladder cancer.

Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, Shipley WU.

J Clin Oncol. 1997 Mar;15(3):1022-9.

PMID:
9060542
[PubMed - indexed for MEDLINE]
Free Article
17.

Bladder-sparing treatment of invasive bladder cancer.

Rivera I, Wajsman Z.

Cancer Control. 2000 Jul-Aug;7(4):340-6. Review.

PMID:
10895128
[PubMed - indexed for MEDLINE]
18.

Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.

Wang J, Wang FW.

Urol Int. 2011;86(4):453-60. doi: 10.1159/000324263. Epub 2011 Apr 28.

PMID:
21525723
[PubMed - indexed for MEDLINE]
19.

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.

Scrimger RA, Murtha AD, Parliament MB, Venner PM, Hanson J, Houle G, Chetner M.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):23-30.

PMID:
11516847
[PubMed - indexed for MEDLINE]
20.

Use of radical cystectomy for patients with invasive bladder cancer.

Gore JL, Litwin MS, Lai J, Yano EM, Madison R, Setodji C, Adams JL, Saigal CS; Urologic Diseases in America Project.

J Natl Cancer Inst. 2010 Jun 2;102(11):802-11. doi: 10.1093/jnci/djq121. Epub 2010 Apr 16.

PMID:
20400716
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk